Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.41 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.38 |
| ▸ | SSTR4 known ✓ | P31391 | 3/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 12/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL28693763 | 0.91 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3ADRB2HTR1A | |
| Methacrylic Acid SCHEMBL1405941 | 0.90 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3ADRB2HTR1A | |
| SCHEMBL3168 | 0.88 | — | — | |
| SCHEMBL322796 | 0.88 | — | — | |
| Fluoride SCHEMBL7750151 | 0.88 | — | — | |
| SCHEMBL12524834 | 0.88 | — | — | |
| SCHEMBL7097741 | 0.88 | — | — | |
| Pivalate SCHEMBL5094974 | 0.88 | SSTR4 (0.40) | SLC6A2SLC6A4SLC6A3ADRB2HTR1A | |
| Butyric Acid SCHEMBL25264905 | 0.86 | FFAR3 (0.42) | SLC6A2SLC6A4SLC6A3ADRB2HTR1A | |
| Acrylic Acid SCHEMBL1405781 | 0.86 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3ADRB2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9939352-B2 | Method and system for determining the concentration of an analyte in a fluid sample | LABCYTE, INC. (US) | 2018-04-10 | — | — | US | claimed |
| EP-3207374-A1 | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A FLUID SAMPLE | Labcyte Inc. (US) | 2017-08-23 | — | — | EP | claimed |
| WO-2016061592-A1 | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A FLUID SAMPLE | LABCYTE INC. (US) | 2016-04-21 | — | — | WO | claimed |
| US-20160109336-A1 | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A FLUID SAMPLE | LABCYTE, INC. | 2016-04-21 | — | — | US | claimed |
| WO-2022072560-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2022-04-07 | — | — | WO | disclosed |
| EP-3207374-B1 | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A FLUID SAMPLE | LABCYTE INC (US) | 2021-05-12 | — | — | EP | disclosed |
| US-9939352-B2 | Method and system for determining the concentration of an analyte in a fluid sample | LABCYTE, INC. (US) | 2018-04-10 | — | — | US | disclosed |
| EP-3207374-A1 | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A FLUID SAMPLE | Labcyte Inc. (US) | 2017-08-23 | — | — | EP | disclosed |
| WO-2016061592-A1 | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A FLUID SAMPLE | LABCYTE INC. (US) | 2016-04-21 | — | — | WO | disclosed |
| US-20160109336-A1 | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A FLUID SAMPLE | LABCYTE, INC. | 2016-04-21 | — | — | US | disclosed |
| WO-2015077660-A1 | ENZYME REACTOR SYSTEM ENABLING ENHANCED ENZYMATIC DIGESTION, ANALYTE SOLUBILITY AND IMPROVED MASS SPECTROMETRIC COMPATIBILITY | PERFINITY BIOSCIENCES, INC (US) | 2015-05-28 | — | — | WO | disclosed |
| EP-1341813-A1 | USE OF L-CARNITINE AS STABILIZING AGENT OF PROTEINS | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2003-09-10 | — | — | EP | disclosed |
| US-5095005-A | For foods | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1992-03-10 | — | — | US | disclosed |
| EP-0458903-A1 | SOLUBLE ANALOGS OF THROMBOMODULIN | CODON (US) | 1991-12-04 | — | — | EP | disclosed |
| EP-0391407-A1 | Polypeptide and antibacterial preparations containing the same | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1990-10-10 | — | — | EP | disclosed |
| US-4956281-A | Polypeptides, codes, binding, genetic engineering | BIOGEN, INC. (US) | 1990-09-11 | — | — | US | disclosed |
| WO-1990010081-A1 | SOLUBLE ANALOGS OF THROMBOMODULIN | CODON (US) | 1990-09-07 | — | — | WO | disclosed |
| EP-0315683-A4 | DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3. | BIOGEN NV (NL) | 1990-02-05 | — | — | EP | disclosed |
| EP-0315683-A1 | DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 | BIOGEN, INC. (US) | 1989-05-17 | — | — | EP | disclosed |
| WO-1988009820-A1 | DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 | BIOGEN N.V. (AN) | 1988-12-15 | — | — | WO | disclosed |